HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

63-year survival after Blalock-Taussig shunt operation in a patient with single ventricle, tricuspid atresia, and pulmonary stenosis.

Abstract
A 63-year-old female with complex congenital heart disease underwent a classical Blalock-Taussig (B-T) shunt operation at the age of 3 years in 1948. The cardiac morphology was not amenable to further definite surgical repair in that period of time. With this palliative operation, the patient survived to the age of 63 years and now presented with exercise intolerance and significant desaturation. Cardiac catheterization with angiography revealed a severe stenosis of the B-T shunt at the pulmonary end. Balloon dilation and stent implantation could be performed successfully. Follow-up after 5 months showed a patent B-T shunt and an increase of oxygen saturation from 65% to 80% and mild improvement of pulmonary blood flow and exercise tolerance.
AuthorsWerner Scholtz, Smita R Jategaonkar, Zisis Dimitriadis, Nikolaus A Haas, Dieter Horstkotte
JournalCongenital heart disease (Congenit Heart Dis) 2011 Mar-Apr Vol. 6 Issue 2 Pg. 179-82 ISSN: 1747-0803 [Electronic] United States
PMID21426531 (Publication Type: Case Reports, Journal Article)
Copyright© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.
Chemical References
  • Oxygen
Topics
  • Abnormalities, Multiple
  • Blalock-Taussig Procedure (adverse effects)
  • Catheterization (instrumentation)
  • Child, Preschool
  • Exercise Tolerance
  • Female
  • Graft Occlusion, Vascular (blood, diagnosis, etiology, physiopathology, therapy)
  • Heart Defects, Congenital (physiopathology, surgery)
  • Heart Ventricles (abnormalities, surgery)
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Oxygen (blood)
  • Palliative Care
  • Pulmonary Circulation
  • Pulmonary Valve Stenosis (surgery)
  • Severity of Illness Index
  • Stents
  • Time Factors
  • Treatment Outcome
  • Tricuspid Atresia (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: